HERCEPTIN

Formula & Concentration

HERCEPTIN – trastuzumab 150 mg intravenous solution

Manufacturer

Genentech Inc

Indications

HER2-positive gastric adenocarcinoma; HER2+ adenocarcinoma of gastroesophageal junction; HER2-positive carcinoma of breast

Product Options

Package Size

NDC #

Presentation

150 MG

50242-0132-01

POWDER

Shelf Life and Storage

Fridge (2-8°C)